Skip to main content

Table 1 Demographics and characteristics related to AAS use

From: Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study

 

Whole sample (= 90)

Treatment seeking group (n = 41)

Non-treatment seeking group (n = 49)

 

Mean (SD)

 

Mean (SD)

Range

Mean (SD)

Range

t

p-value

Age (years)

 38.9 (10.6)

 

36.3 (11.3)

22-74

41.2 (9.5)

25-60

2.216

0.029*

Education (years)

 14.8 (2.4)22

 

14.8 (2.3)

9-19

14.8 (2.6)

10-23

-0.072

0.943

AAS debut age

 22.6 (7.8)

 

21.6 (7.8)

15-55

23.5 (7.9)

16-50

1.161

0.249

Accumulated AAS use (years)

 11.9 (8.5)

 

11.6 (8.7)

1.5-29

12.2 (8.4)

1-29

0.338

0.736

 

n

%

n

%

n

%

χ2

p-value

AAS dependence (SCID, 5 missing)

52 (n = 85)

61.2

24 (n = 40)

60.0

28 (n = 45)

62.2

0.044

0.834

Current AAS use

59

65.6

25

61.0

34

69.4

0.7

0.403

Current employment

70

77.7

31

75.6

39

79.6

0.205

0.651

Student

15

16.7

6

14.6

9

18.4

0.224

0.636

Children

57

63.3

26

63.4

31

63.3

0.002

0.988

AU/week (mean, SD, range, t)

2.2 (2.9)

0-12

2.4 (3.3)

0-12

1.9 (2.6)

0-10

0.797

0.428

AUDIT ≥ 8

17

19.5

6

15.4

11

22.9

0.776

0.378

Regular illicit substance use

26

28.9

10

24.4

16

32.7

0.742

0.389

DUDIT ≥ 6

12

13.3

7

17.1

5

10.2

0.912

0.340

Psychopharmacological treatment, life-time

36

40

19

46.3

17

34.7

1.262

0.261

Psychopharmacological treatment, current

13

14.4

8

19.2

5

10.2

1.565

0.211

 Antidepressants, life-time

21

23.3

13

31.7

8

16.3

3.195

0.074

 Antidepressants, current

5

5.5

2

4.9

3

6.1

0.066

1.000

 Anxiolytics, life-time

23

25.5

12

29.3

11

22.4

0.546

0.460

 Anxiolytics, current

9

10

8

19.5

1

2.0

7.571

0.010*

 Antipsychotics, life-time

5

5.5

3

7.3

2

4.1

0.452

0.656

 Antipsychotics, current

4

4.4

2

4.9

2

4.1

0.033

1.000

  1. Data are presented as means (standard deviation, SD) and n (%). *Significant difference between the groups (p ≤ 0.05). Fischer’s exact test was used when the expected number were based upon less than five cases. AAS = Anabolic-androgenic steroids, SCID = Structured Clinical Interview for DSM-IV, SD = standard deviation, AU = Alcohol units, AUDIT = Alcohol Use Disorders Identification Test, DUDIT = Drug Use Disorders Identification Test.